Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Enliven Therapeutics Inc.

ELVN
Current price
24.41 USD -0.59 USD (-2.36%)
Last closed 24.92 USD
Company
ISIN US29337E1029
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 1 367 989 248 USD
Yield for 12 month +134.26 %
1Y
3Y
5Y
10Y
15Y
ELVN
21.11.2021 - 28.11.2021

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. The company's lead product candidates comprise ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial in adults with solid tumors with HER2 alterations. The company is headquartered in Boulder, Colorado. Address: 6200 Lookout Road, Boulder, CO, United States, 80301

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

35.67 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-297 000 USD

Last Year

-622 000 USD

Current Quarter

-79 000 USD

Last Quarter

-79 000 USD

Key Figures ELVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -95 954 000 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -19.55 %
PEG Ratio
Return On Equity TTM -28.37 %
Wall Street Target Price 35.67 USD
Revenue TTM
Book Value 6.46 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -1.91 USD
Diluted Eps TTM -1.91 USD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ELVN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ELVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:4
Payout Ratio
Last Split Date 24.02.2023
Dividend Date

Stock Valuation ELVN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -6.2821
Price Book MRQ 4.4862

Financials ELVN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ELVN

For 52 weeks

9.8 USD 30.03 USD
50 Day MA 25.86 USD
Shares Short Prior Month 6 104 584
200 Day MA 21.62 USD
Short Ratio 18.76
Shares Short 6 512 482
Short Percent 34.11 %